Cohance Lifesciences Ltd
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|
| Revenue | 566.76 | 487.70 | 524.09 |
| Operating Expense | 467.49 | 383.66 | 366.93 |
| Net Profit | 34.56 | 47.29 | 94.29 |
| Net Profit Margin | 6.10% | 9.70% | 17.99% |
| Earning Per Share | 0.90 | 1.24 | 2.46 |
| EBIDTA | 98.47 | 98.56 | 156.94 |
| Effective Tax Rate | 21.24% | 12.17% | 16.68% |
Particulars
Mar 2026
Revenue566.76
Operating Expense467.49
Net Profit34.56
Net Profit Margin6.10
Earning Per Share0.90
EBIDTA98.47
Effective Tax Rate21.24
